Industry: Chemical & Material
Published Date: 2026-01-05
Pages: 138 Pages
Report ld: 5574885
Request Sample
Customized Report
Nicotinamide Riboside (NR) Market Size(US$)

CAGR 2026-2032
8.3%
Market Size,2032
USD 48.14
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Nicotinamide Riboside (NR) market was valued at US$ 27.73 million in 2025 and is anticipated to reach US$ 48.14 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nicotinamide Riboside (NR) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.
The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.
The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.
Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.
Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.
In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.
This report delivers a comprehensive overview of the global Nicotinamide Riboside (NR) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nicotinamide Riboside (NR). The Nicotinamide Riboside (NR) market size, estimates, and forecasts are provided in terms of shipments (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nicotinamide Riboside (NR) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nicotinamide Riboside (NR) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Nicotinamide Riboside (NR) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Nicotinamide Riboside (NR) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Nicotinamide Riboside (NR) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Nicotinamide Riboside (NR) Market Overview
1.1 Product Definition
1.2 Nicotinamide Riboside (NR) by Type
1.2.1 Global Nicotinamide Riboside (NR) Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity ≤98%
1.2.3 Purity >98%
1.3 Nicotinamide Riboside (NR) by Application
1.3.1 Global Nicotinamide Riboside (NR) Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Health Supplement
1.3.3 Pharmaceutical Additives
1.4 Global Market Growth Prospects
1.4.1 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Nicotinamide Riboside (NR) Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts (2021–2032)
1.4.4 Global Nicotinamide Riboside (NR) Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nicotinamide Riboside (NR) Production Market Share by Manufacturers (2021–2026)
2.2 Global Nicotinamide Riboside (NR) Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Nicotinamide Riboside (NR), Industry Ranking, 2024 vs 2025
2.4 Global Nicotinamide Riboside (NR) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Nicotinamide Riboside (NR) Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Nicotinamide Riboside (NR), Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Nicotinamide Riboside (NR), Product Offerings and Applications
2.8 Global Key Manufacturers of Nicotinamide Riboside (NR), Date of Entry into the Industry
2.9 Nicotinamide Riboside (NR) Market Competitive Situation and Trends
2.9.1 Nicotinamide Riboside (NR) Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Nicotinamide Riboside (NR) Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Nicotinamide Riboside (NR) Production by Region
3.1 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Nicotinamide Riboside (NR) Production Value by Region (2021–2032)
3.2.1 Global Nicotinamide Riboside (NR) Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Nicotinamide Riboside (NR) by Region (2027–2032)
3.3 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Nicotinamide Riboside (NR) Production Volume by Region (2021–2032)
3.4.1 Global Nicotinamide Riboside (NR) Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Nicotinamide Riboside (NR) by Region (2027–2032)
3.5 Global Nicotinamide Riboside (NR) Market Price Analysis by Region (2021–2026)
3.6 Global Nicotinamide Riboside (NR) Production, Value, and Year-over-Year Growth
3.6.1 North America Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021–2032)
3.6.2 China Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021–2032)
4 Nicotinamide Riboside (NR) Consumption by Region
4.1 Global Nicotinamide Riboside (NR) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Nicotinamide Riboside (NR) Consumption by Region (2021–2032)
4.2.1 Global Nicotinamide Riboside (NR) Consumption by Region (2021–2026)
4.2.2 Global Nicotinamide Riboside (NR) Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Nicotinamide Riboside (NR) Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Nicotinamide Riboside (NR) Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nicotinamide Riboside (NR) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Nicotinamide Riboside (NR) Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Nicotinamide Riboside (NR) Production by Type (2021–2032)
5.1.1 Global Nicotinamide Riboside (NR) Production by Type (2021–2026)
5.1.2 Global Nicotinamide Riboside (NR) Production by Type (2027–2032)
5.1.3 Global Nicotinamide Riboside (NR) Production Market Share by Type (2021–2032)
5.2 Global Nicotinamide Riboside (NR) Production Value by Type (2021–2032)
5.2.1 Global Nicotinamide Riboside (NR) Production Value by Type (2021–2026)
5.2.2 Global Nicotinamide Riboside (NR) Production Value by Type (2027–2032)
5.2.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2021–2032)
5.3 Global Nicotinamide Riboside (NR) Price by Type (2021–2032)
6 Segment by Application
6.1 Global Nicotinamide Riboside (NR) Production by Application (2021–2032)
6.1.1 Global Nicotinamide Riboside (NR) Production by Application (2021–2026)
6.1.2 Global Nicotinamide Riboside (NR) Production by Application (2027–2032)
6.1.3 Global Nicotinamide Riboside (NR) Production Market Share by Application (2021–2032)
6.2 Global Nicotinamide Riboside (NR) Production Value by Application (2021–2032)
6.2.1 Global Nicotinamide Riboside (NR) Production Value by Application (2021–2026)
6.2.2 Global Nicotinamide Riboside (NR) Production Value by Application (2027–2032)
6.2.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2021–2032)
6.3 Global Nicotinamide Riboside (NR) Price by Application (2021–2032)
7 Key Companies Profiled
7.1 ChromaDex
7.1.1 ChromaDex Nicotinamide Riboside (NR) Company Information
7.1.2 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
7.1.3 ChromaDex Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 ChromaDex Main Business and Markets Served
7.1.5 ChromaDex Recent Developments/Updates
7.2 Genex Formulas
7.2.1 Genex Formulas Nicotinamide Riboside (NR) Company Information
7.2.2 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
7.2.3 Genex Formulas Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Genex Formulas Main Business and Markets Served
7.2.5 Genex Formulas Recent Developments/Updates
7.3 Shandong Tianming Pharmaceutical
7.3.1 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Company Information
7.3.2 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
7.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Shandong Tianming Pharmaceutical Main Business and Markets Served
7.3.5 Shandong Tianming Pharmaceutical Recent Developments/Updates
7.4 Bontac
7.4.1 Bontac Nicotinamide Riboside (NR) Company Information
7.4.2 Bontac Nicotinamide Riboside (NR) Product Portfolio
7.4.3 Bontac Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Bontac Main Business and Markets Served
7.4.5 Bontac Recent Developments/Updates
7.5 Longer Livetech
7.5.1 Longer Livetech Nicotinamide Riboside (NR) Company Information
7.5.2 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
7.5.3 Longer Livetech Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Longer Livetech Main Business and Markets Served
7.5.5 Longer Livetech Recent Developments/Updates
7.6 Tiantai Biotechnology
7.6.1 Tiantai Biotechnology Nicotinamide Riboside (NR) Company Information
7.6.2 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
7.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Tiantai Biotechnology Main Business and Markets Served
7.6.5 Tiantai Biotechnology Recent Developments/Updates
7.7 EnzymeWorks
7.7.1 EnzymeWorks Nicotinamide Riboside (NR) Company Information
7.7.2 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
7.7.3 EnzymeWorks Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 EnzymeWorks Main Business and Markets Served
7.7.5 EnzymeWorks Recent Developments/Updates
7.8 Suzhou MyLand Pharm & Nutrition
7.8.1 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Company Information
7.8.2 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
7.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Suzhou MyLand Pharm & Nutrition Main Business and Markets Served
7.8.5 Suzhou MyLand Pharm & Nutrition Recent Developments/Updates
7.9 Shenzhen Ejion Biotechnology
7.9.1 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Company Information
7.9.2 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
7.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Shenzhen Ejion Biotechnology Main Business and Markets Served
7.9.5 Shenzhen Ejion Biotechnology Recent Developments/Updates
7.10 Zhejiang Jiahua
7.10.1 Zhejiang Jiahua Nicotinamide Riboside (NR) Company Information
7.10.2 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
7.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Zhejiang Jiahua Main Business and Markets Served
7.10.5 Zhejiang Jiahua Recent Developments/Updates
7.11 Weitai Pharmaceutical
7.11.1 Weitai Pharmaceutical Nicotinamide Riboside (NR) Company Information
7.11.2 Weitai Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
7.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Weitai Pharmaceutical Main Business and Markets Served
7.11.5 Weitai Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nicotinamide Riboside (NR) Industry Chain Analysis
8.2 Nicotinamide Riboside (NR) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nicotinamide Riboside (NR) Production Modes and Processes
8.4 Nicotinamide Riboside (NR) Sales and Marketing
8.4.1 Nicotinamide Riboside (NR) Sales Channels
8.4.2 Nicotinamide Riboside (NR) Distributors
8.5 Nicotinamide Riboside (NR) Customer Analysis
9 Nicotinamide Riboside (NR) Market Dynamics
9.1 Nicotinamide Riboside (NR) Industry Trends
9.2 Nicotinamide Riboside (NR) Market Drivers
9.3 Nicotinamide Riboside (NR) Market Challenges
9.4 Nicotinamide Riboside (NR) Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Nicotinamide Riboside (NR) market size was US$ 27.73 million in 2025 and is forecast to reach a readjusted size of US$ 48.14 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 94
USD 4250.00
(Single User License)
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 27.73 million in 2025 and is projected to reach US$ 48.14 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
The global Nicotinamide Riboside (NR) market size was US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
The global Nicotinamide Riboside (NR) market is projected to grow from US$ 25.8 million in 2024 to US$ 44.8 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 162
USD 4900.00
(Single User License)
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 112
USD 3950.00
(Single User License)
The global market for Nicotinamide Riboside (NR) was valued at US$ 25.8 million in the year 2024 and is projected to reach a revised size of US$ 44.8 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published Date: 2025-01-19
Pages: 103
USD 2900.00
(Single User License)
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-17
Pages: 174
USD 5600.00
(Single User License)
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-16
Pages: 143
USD 5900.00
(Single User License)
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-01-18
Pages: 121
USD 3950.00
(Single User License)
The global Nicotinamide Riboside (NR) market size was US$ 27.73 million in 2025 and is forecast to reach a readjusted size of US$ 48.14 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 94
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 27.73 million in 2025 and is projected to reach US$ 48.14 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
The global Nicotinamide Riboside (NR) market size was US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
The global Nicotinamide Riboside (NR) market is projected to grow from US$ 25.8 million in 2024 to US$ 44.8 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 162
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 112
The global market for Nicotinamide Riboside (NR) was valued at US$ 25.8 million in the year 2024 and is projected to reach a revised size of US$ 44.8 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-01-19
Pages: 103
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-17
Pages: 174
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-16
Pages: 143
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-07
Pages: 106
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-01-18
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now